Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Many advances in the treatment of juvenile idiopathic arthritis have been underpinned by the development of organizations such as PRINTO and PRCSG. This Perspectives provides a timeline for these advances, including clinical trial designs and diagnostic criteria essential to performing research in this small group of patients whose age necessitates a cautious approach to treatment.